Quantum BioPharma reported a 91% increase in shareholder equity to $9.77 million and a rise in liquidity to $12.22 million as of Q3 2026. The company reduced operating expenses by 32% year-over-year and secured FDA clearance to start a Phase 2 clinical trial for its Lucid-MS drug targeting progressive multiple sclerosis. A Study Start-Up Agreement with Thermo Fisher Scientific was signed to begin trial activities, marking a key step in clinical development. Quantum's strong financial position supports its ongoing operations and future growth plans.
Quantum BioPharma's Q3 2026 financial update provides context for readers following health-sector developments. For readers following health-sector stocks, here is Pluang's market snapshot as of Nov 13, 2026 18:41 WIB: Among 150 priced health-sector US stocks tradable on Pluang, 93 rose and 49 fell today. Takeda Pharmaceutical (TAK) rose 2.18% to USD 21.58 with 100% buy orders, The Cooper Companies (COO) increased 2.14% to USD 63.52, and Dyne Therapeutics (DYN) gained 2.00% to USD 17.35, with typical hold times ranging from 11 to 12 days on Pluang.
KeyBanc lowered its price target for YETI Holdings to $49, suggesting a 27.94% upside from the current $38.30 stock price. This follows YETI's reduction of its full-year adjusted sales growth forecast to about 6% from the previous 7-8%, citing consum...
Bernstein SocGen Group has reduced its price target for Applied Materials to $600, even though the company reported higher sales and profits in Q4 2026 driven by strong demand for semiconductor services, especially AI chips. Applied Materials posted ...
Boralex Inc. announced a private placement of $600 million Canadian dollars in green bonds, split into two series maturing in 2031 and 2036 with interest rates of 4.503% and 5.173%, respectively. This marks Boralex's first issuance of green corporate...
Boralex Inc. announced the issuance of C$600 million in green bonds, split into two series with maturities in 2031 and 2036, bearing interest rates of 4.503% and 5.173% respectively. This marks Boralex's first green-labelled corporate securities offe...
Investec Bank Plc, acting as an exempt principal trader and advisor to DBAY Advisors Limited, disclosed the sale of 25,000 ordinary shares of Logistics Development Group Plc on November 12, 2026. The shares were sold at a price of 23 per unit. There ...
